Andreas Busch
First SEC filing: Jan. 24, 2022 · Latest: Jan. 24, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | ABSI | P | 100,000 | $2.29 | $229,000 | 421,446 Direct | +31.11% | Acquired | 383.4% (price as of 2026-10-02) |
| March 3, 2026 | ABSI | F | 1,257 | $2.80 | $3,520 | 321,446 Direct | -0.39% | Disposed | 295.4% (price as of 2026-10-02) |
| Feb. 3, 2026 | ABSI | F | 1,469 | $2.99 | $4,392 | 322,703 Direct | -0.45% | Disposed | 270.2% (price as of 2026-10-02) |
| Oct. 14, 2025 | ABSI | F | 3,092 | $3.68 | $11,379 | 324,172 Direct | -0.94% | Disposed | 200.8% (price as of 2026-10-02) |
| July 28, 2025 | ABSI | P | 50,000 | $3.04 | $152,000 | 327,264 Direct | +18.03% | Acquired | 264.1% (price as of 2026-10-02) |
| March 3, 2025 | ABSI | A | 23,700 | · | · | 277,264 Direct | +9.35% | Acquired | (price as of 2026-10-02) |
| March 3, 2025 | ABSI | A | 93,700 | · | · | 93,700 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2025 | ABSI | F | 1,469 | $3.71 | $5,450 | 253,564 Direct | -0.58% | Disposed | 198.4% (price as of 2026-10-02) |
| Oct. 12, 2024 | ABSI | F | 3,092 | $4.07 | $12,584 | 255,033 Direct | -1.20% | Disposed | 172.0% (price as of 2026-10-02) |
| Feb. 1, 2024 | ABSI | A | 83,125 | · | · | 258,125 Direct | +47.50% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2024 | ABSI | A | 349,625 | · | · | 349,625 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 12, 2023 | ABSI | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2023 | ABSI | A | 550,000 | · | · | 550,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 3, 2022 | ABSI | A | 2,000,009 | · | · | 2,000,009 Direct | · | Acquired | (price as of 2026-10-02) |
| June 8, 2022 | ABSI | A | 4,783 | · | · | 4,783 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2022 | ABSI | A | 45,180 | · | · | 45,180 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 20, 2022 | KRSA | A | 135,000 | · | · | 135,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 9, 2021 | KRSA | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 9, 2020 | KRSA | P | 125,000 | $2.53 | $316,250 | 254,704 Direct | +96.37% | Acquired | -91.4% (price as of 2026-10-02) |
| Nov. 4, 2020 | KRSA | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 22, 2019 | KRSA | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 15, 2019 | KRSA | P | 125,000 | $1.82 | $227,500 | 125,000 Direct | · | Acquired | -88.0% (price as of 2026-10-02) |
| April 29, 2019 | KRSA | A | 300,000 | · | · | 300,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2025 | ABSI | Stock Option (right to buy) | Common Stock | $3.42 | March 2, 2035 | 93,700 | Acquired |
| Feb. 1, 2024 | ABSI | Stock Option (right to buy) | Common Stock | $4.40 | Jan. 31, 2034 | 349,625 | Acquired |
| March 1, 2023 | ABSI | Stock Option (right to buy) | Common Stock | $2.01 | Feb. 28, 2033 | 550,000 | Acquired |
| Oct. 3, 2022 | ABSI | Stock Option (right to buy) | Common Stock | $2.97 | Oct. 2, 2032 | 2,000,009 | Acquired |
| June 8, 2022 | ABSI | Stock Option (right to buy) | Common Stock | $3.39 | June 7, 2032 | 4,783 | Acquired |
| March 17, 2022 | ABSI | Stock Option (right to buy) | Common Stock | $8.87 | March 16, 2032 | 45,180 | Acquired |
| Jan. 20, 2022 | KRSA | Employee Stock Option (Right to Buy) | Common Stock | $1.21 | Jan. 20, 2032 | 135,000 | Acquired |
| Dec. 9, 2021 | KRSA | Employee Stock Option (Right to Buy) | Common Stock | $1.93 | Dec. 9, 2031 | 75,000 | Acquired |
| Nov. 4, 2020 | KRSA | Employee Stock Option (Right to Buy) | Common Stock | $2.48 | Nov. 4, 2030 | 75,000 | Acquired |
| Nov. 22, 2019 | KRSA | Employee Stock Option (Right to Buy) | Common Stock | $2.01 | Nov. 22, 2029 | 75,000 | Acquired |
| April 29, 2019 | KRSA | Employee Stock Option (Right to Buy) | Common Stock | $15.40 | April 29, 2029 | 300,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $712,797 | · | $81,054 | $239,422 | $384,910 | · | $142,954 | $1,561,137 |
| 2024 | $654,095 | · | $365,750 | $1,106,612 | $392,457 | · | $125,506 | $2,644,420 |
| 2023 | $630,209 | · | $231,000 | $787,419 | $415,938 | · | $86,737 | $2,151,303 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $492,320 | · | · | $113,183 | $135,922 | · | $41,119 | $782,544 |
| 2020 | $479,667 | · | · | $144,495 | $138,144 | · | $44,613 | $806,919 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.